Sumitomo Life Insurance CO Neurocrine Biosciences Inc Transaction History

Sumitomo Life Insurance CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 17, 2019	SELL	$69.31 - $91.53 $688,872 - $909,716	-9,939 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$68.32 - $124.36 $12,297 - $22,384	180 Added 1.84%	9,939 $710,000
Q3 2018 Oct 18, 2018	BUY	$98.88 - $125.85 $964,969 - $1.23 Million	9,759 New	9,759 $1.2 Million

627

94.3M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Sumitomo Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Sumitomo Life Insurance CO with notifications on news.